SC
Stempoint Capital Portfolio holdings
AUM
$311M
This Quarter Return
+35.12%
1 Year Return
+15.22%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$374M
AUM Growth
+$374M
(+7.5%)
Cap. Flow
-$20.9M
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
57.86%
Holding
84
New
17
Increased
16
Reduced
11
Closed
27
Top Buys
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$17.3M |
| 2 |
AUTL
Autolus Therapeutics
AUTL
|
$16M |
| 3 |
Roivant Sciences
ROIV
|
$14.6M |
| 4 |
Immunovant
IMVT
|
$9.86M |
| 5 |
Cabaletta Bio
CABA
|
$9.44M |
Top Sells
| 1 |
Merus
MRUS
|
$12.1M |
| 2 |
Arcellx
ACLX
|
$12.1M |
| 3 |
Spyre Therapeutics
SYRE
|
$12M |
| 4 |
Protagonist Therapeutics
PTGX
|
$11.8M |
| 5 |
BridgeBio Pharma
BBIO
|
$10.3M |
Sector Composition
| 1 | Healthcare | 100% |
